Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchloxl4fibrosisoncology

Review Positions LOXL4 at Intersection of Fibrosis and Tumor Progression

Human Cell review summarizes LOXL4 as a regulatory factor linking fibrotic remodeling to cancer progression.

PR
By Priya Raman · Science Reporter
Sep 15 20:00 ETSource: Human cell

The wire

  1. 01Authors review LOXL4 biology across fibrosis and tumor progression.
  2. 02Could inform target selection for anti-fibrotic and oncology programs.
  3. 03No therapeutic candidates or clinical data are described.

From the source

LOXL4: a key regulatory factor at the intersection of fibrosis and tumor progression

Human cell · 2026 Sep 16 · Tian Y, Li Q et al.

Read at pubmed.ncbi.nlm.nih.gov
Source URL https://pubmed.ncbi.nlm.nih.gov/42749970/